IP Library Granted Patent US 11,203,759
Granted Patent B2
US 11,203,759 · App. 15/698,302 · Granted Dec 21, 2021

Oxygen-responsive bacterial gene switch

Inventors: Patricia J. Kiley (Middleton, WI); Dan M. Park (Dublin, CA)
Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
C12N15/70C12N15/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,203,759
App. No.
15/698,302
Granted
Dec 21, 2021
Kind
B2
Abstract

The invention provided herein relates to sequence determinants that elicit certain levels of gene expression and methods for obtaining engineered ligand-responsive gene switches comprising these sequence determinants. More particularly, the invention provided herein relates to molecular building blocks (i.e., discrete nucleotide sequences), synthetic ligand-responsive gene switches comprising an assembly of these molecular building blocks, and methods of using synthetic ligand-responsive gene switches as customizable and controllable expression systems and sensors.

Claims (42)

1. A vector comprising a synthetic gene switch comprising

(i) a first sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39;

(ii) a second sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39; and

(iii) a third sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the first and second sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, the second and third sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, and the first and third sequence determinant portions are separated by a 22-basepair center-to-center spacing interval, and with the proviso that if the first sequence determinant portion is SEQ ID NO:2, the second sequence determinant portion is SEQ ID NO:37, and the third sequence determinant portion is SEQ ID NO:39 the synthetic gene switch additionally comprises a fourth sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the synthetic gene switch is operably linked to a promoter.

2. The vector of claim 1 , wherein the synthetic gene switch is positioned with respect to the promoter on the vector to confer ArcA-dependent promoter activity.

3. A bacterial host cell comprising the vector of claim 1 .

4. The bacterial host cell of claim 3 , wherein the cell is an E. coli cell.

5. The vector of claim 1 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:5-16.

6. The vector of claim 5 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:18-32.

7. An expression vector comprising,

a synthetic gene switch comprising:

(i) a first sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39;

(ii) a second sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39; and

(iii) a third sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the first and second sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, the second and third sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, and the first and third sequence determinant portions are separated by a 22-basepair center-to-center spacing interval, and with the proviso that if the first sequence determinant portion is SEQ ID NO:2, the second sequence determinant portion is SEQ ID NO:37, and the third sequence determinant portion is SEQ ID NO:39, the synthetic gene switch additionally comprises a fourth sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the synthetic gene switch additionally comprises at least a portion of an RNA polymerase binding site; and

a target nucleic acid sequence downstream of the synthetic gene switch.

8. The expression vector of claim 7 , wherein the synthetic gene switch is operably linked to a promoter.

9. A bacterial host cell comprising the vector of claim 7 .

10. The bacterial host cell of claim 9 , wherein the cell is an E. coli cell.

11. The expression vector of claim 7 , wherein the synthetic gene switch comprises a fourth sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39 and wherein the fourth sequence determinant portion is separated from either the first or third sequence determinant portions by an 11-basepair center-to-center spacing interval.

12. The expression vector of claim 7 , wherein the RNA polymerase binding site is a binding site for bacterial σ 70 -RNA polymerase.

13. The vector of claim 7 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:5-16.

14. The vector of claim 13 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:18-32.

15. A method for modulating gene expression of a target nucleic acid sequence, the method comprising:

introducing into a host cell an expression vector of claim 7 ; and

subjecting the host cell to a change in oxygen concentration until the gene expression level of the target nucleic acid sequence is modulated.

16. The method of claim 15 , wherein the gene expression level is modulated under anaerobic conditions.

17. An expression vector comprising,

a synthetic gene switch comprising:

(i) a first sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39;

(ii) a second sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39; and

(iii) a third sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the first and second sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, the second and third sequence determinant portions are separated by an 11-basepair center-to-center spacing interval, and the first and third sequence determinant portions are separated by a 22-basepair center-to-center spacing interval, and with the proviso that if the first sequence determinant portion is SEQ ID NO:2, the second sequence determinant portion is SEQ ID NO:37, and the third sequence determinant portion is SEQ ID NO:39, the synthetic gene switch additionally comprises a fourth sequence determinant portion selected from the group consisting of SEQ ID NOs:2, 4, 36, 37, 38, and 39,

wherein the synthetic gene switch comprises a promoter element; and

a target nucleic acid sequence downstream of the synthetic gene switch.

18. The vector of claim 17 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:5-16.

19. The vector of claim 18 , wherein the synthetic gene switch comprises a sequence selected from the group consisting of SEQ ID NOs:18-32.

20. A bacterial host cell comprising the vector of claim 17 .

21. The bacterial host cell of claim 20 , wherein the cell is an E. coli cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: KILEY, PATRICIA; PARK, DAN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 047434/0071 →
CONFIRMATORY LICENSE Recorded Nov 15, 2017
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044763/0319 →
Continuity (3)
Continuation 14597466 · Jan 15, 2015
Provisional Application 61928292 · Jan 16, 2014
Related Publication 20180010138A1 · Jan 11, 2018